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Abstract
CD4 T cell deficiency or defective IFNc signaling render humans and mice highly susceptible to Mycobacterium tuberculosis
(Mtb) infection. The prevailing model is that Th1 CD4 T cells produce IFNc to activate bactericidal effector mechanisms of
infected macrophages. Here we test this model by directly interrogating the effector functions of Th1 CD4 T cells required to
control Mtb in vivo. While Th1 CD4 T cells specific for the Mtb antigen ESAT-6 restrict in vivo Mtb growth, this inhibition is
independent of IFNc or TNF and does not require the perforin or FAS effector pathways. Adoptive transfer of Th17 CD4 T
cells specific for ESAT-6 partially inhibited Mtb growth while Th2 CD4 T cells were largely ineffective. These results imply a
previously unrecognized IFNc/TNF independent pathway that efficiently controls Mtb and suggest that optimization of this
alternative effector function may provide new therapeutic avenues to combat Mtb through vaccination.
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Introduction
IFNc is essential for defense against Mtb infection, as revealed
by experimental studies using knockout mice and the unusually
severe mycobacterial infections in patients with defects in the IFNc
or IL-12 signaling pathways [1,2,3,4]. The role of CD4 T cells in
defense against Mtb infection has been inferred from the increased
reactivation of latent Mtb infections in CD4 T cell deficient
patients following HIV infection and severe tuberculosis observed
in CD4 T cell-deficient mice [3,5]. These clinical and experimen-
tal findings have led to a widely accepted model positing that the
critical immunologic mechanism of anti-mycobacterial immunity
involves CD4 T cells that secrete IFNc to activate bactericidal
functions of Mtb-infected macrophages. Substantial evidence
indicates that IFNc can activate murine macrophages to limit
Mtb growth [6–7] but the relative importance of this bactericidal
mechanism and the cellular sources of IFNc are unknown.
Evidence for an CD4 T cell dependent, IFNc independent
mechanism of killing has been suggested by the finding that the
frequency of Mtb-specific, IFNc-producing cells following immu-
nization does not correlate with protection against infection and
that depletion of CD4 cells exacerbates Mtb infection in mice
despite the ongoing expression of IFNc [8,9,10,11,12].
In this report, we have assessed the requirement of IFNc in
protection by Mtb specific CD4 T cells. Using a model of adoptive
transfer of Mtb specific effector CD4 T cells, we provide evidence
for the surprising conclusion that IFNc is not a required mediator
of CD4 T cell defense to Mtb. In support of this finding is our
discovery that key mediators of IFNc- dependant immunity,
inducible nitric oxide synthase and phagocyte oxidase, were not
required for the early protective events mediated by adoptively
transferred Th-1 skewed CD4 T cells. Although Th1-skewed cells
were superior to Th2 or Th17-skewed cells in defense to Mtb,
surprisingly, protection by Th1 –skewed cells was independent of
the master regulator of Th1 differentiation, T-bet. Our results are
contrary to a dominant role for IFNc production by effector CD4
in Mtb protection, but strongly support a requirement for Th1
mediated immunity to Mtb.
Results/Discussion
IFN-gamma and iNOS independent control of M.
tuberculosis infection
To investigate the contribution of IFNc production by Mtb-
specific CD4 T cells during infection, we compared the ability of
WT and IFNc deficient, Mtb-specific CD4 T cells derived from
the C7 TCR transgenic mouse [13] , to protect mice from
infection. Naive C7 CD4 T cells, specific for the immunodominant
Mtb antigen ESAT-6 in the context of the IA
b MHC class II
molecule, were activated in vitro under Th1-skewing conditions
[13] and transferred into WT mice. To be certain that protection
mediated by C7 CD4 T cells is antigen specific, we generated a
strain of M. tuberculosis in which a key TCR contact residue in the
ESAT-6 epitope (E12) was mutated to alanine to abolish C7
recognition (Figure 1A). M. tuberculosis ESAT6-E12A was fully
virulent, but was not affected by Th1-differentiated C7 cells,
whereas wild type M. tuberculosis titers were reduced by
approximately 50 fold (Figure 1B and C).
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Th1 effector cells into WT mice that were subsequently aerosol-
infected with Mtb and, twenty-one days later, the number of
bacteria in the lungs was determined. Surprisingly, both C7.WT
and C7.IFNc deficient cells provided similar levels of protection
compared to animals that did not receive cells (Figure 2A),
indicating that IFNc production by adoptively transferred effector
CD4 T cells is not required for protection when these cells are
present at the time of infection. To examine whether IFNc-
independent restriction of Mtb growth is a specific property of C7
transgenic T cell populations or a general property of Mtb specific
T cells, we generated bone marrow chimeric mice in which wild
type recipient C57BL/6 mice received a 50:50 mixture of bone
marrow from Rag2-deficient and IFNc-deficient donors. In these
chimeric mice, all T cells are IFNc-deficient, while Rag2-in-
dependent innate immune cells, such as NK cells, macrophages,
monocytes and DCs are capable of producing IFNc. Bone marrow
chimeric mice with IFNc-deficient T cells were similarly resistant
to Mtb infection as mice receiving wild type T cells, supporting our
conclusion that T cells can mediate protection without producing
IFNg and that our results with transgenic T cells extend to native
T cell populations (Figure S1). We also examined whether naı ¨ve
C7 cells could limit M. tuberculosis growth and whether this effect is
independent of IFN-c. 10,000 naı ¨ve C7 cells significantly reduced
M. tuberculosis bacterial load in the lung at 22 days (Figure S1B).
IFNc deficient T cells also significantly reduced bacterial loads and
there was no significant difference in the ability of wild type and
IFNc deficient naı ¨ve cells to control M. tuberculosis growth (Figure
S1B).
Because IFNc is essential for effective immune control of Mtb,
we speculated that IFNc deficient C7 cells might recruit IFNc-
expressing host-derived cells (e.g. Natural Killer cells or endoge-
nous CD4 or CD8 T cells) to sites of mycobacterial infection. In
this way, host-derived IFNc might activate the expression of
mycobactericidal factors. To address this hypothesis, we tested that
Figure 1. Mutation in amino acid 12 of ESAT6 prevents protection by C7 effector cells. (A) Naı ¨ve C7 CD4 T cells were cultured in the
presence of irradiated APCs (T cell depleted splenocytes) and either native ESAT6 peptide (aa 1–20) or mutated ESAT6 peptide in which amino acid
number 12 was changed from glutamic acid to alanine (E12A). Analysis of tritiated thymidine incorporation reveals C7 CD4 T cells do not respond to
ESAT6 (E12A). (B) B6 mice were infected with the indicated strains of Mtb and CFUs determined. Each dot represents data from 4–10 mice.
(C) Bacterial numbers from mice that received Th1-skewed C7 effector cells and were subsequently infected with Desat6+wt or Desat6+E12A.
Bacterial numbers were determined 21 days post infection.
doi:10.1371/journal.ppat.1002052.g001
Author Summary
Mycobacterium tuberculosis (Mtb) is an inhaled pathogen
that primarily infects the lungs and causes the disease,
tuberculosis. Recent WHO statistics show that more than 2
billion people are infected with Mtb, of these over 1
million people die every year. Researchers over the last
several decades have tried to determine how our immune
system fights Mtb infection. It is known that CD4 T cells,
and the pro-inflammatory cytokine, IFNc, are required to
control Mtb infection in humans and in mice. Based on
these observations, it is commonly assumed that vaccines
that maximize IFNc-producing Mtb-specific CD4 T cell
numbers will be the most effective. For the first time, we
tested this idea directly and our results led us to the
unexpected finding that Mtb specific CD4 T cells do not
require IFNc in order to protect mice from Mtb infection.
Our results challenge the model that optimization of IFNc-
producing CD4 T cells will optimize vaccine induced
protection against M. tuberculosis.
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mice lacking IFNc. Remarkably, both WT and IFNc-deficient C7
effector cells protected hosts lacking IFNc, although in this setting
IFNc-deficient T cells were slightly but significantly less effective
than WT C7 cells at limiting in vivo growth of Mtb. Nevertheless,
compared to IFNc deficient mice that did not receive T cells,
animals that received C7 IFNc deficient effectors had ,30 fold
reduction in bacterial numbers in the lungs at day 21 following
infection (Figure 2B). This result demonstrates that CD4 T cells
have a highly effective effector pathway to control Mtb that is
completely independent of IFNc.
During murine infection with Mtb, IFNc signaling induces
NOS2 (inducible nitric oxide synthase), leading to the generation
of nitric oxide (NO) which can kill mycobacteria [14]. To
determine whether adoptively transferred C7 T cells mediate
protection by inducing NOS2, we transferred C7 T cells into
NOS2 deficient mice. WT C7 effectors were effective at protecting
both NOS2 and PHOX deficient mice from infection, resulting in
,70 fold reduction in bacterial numbers in NOS2 or PHOX
deficient C7-recipients compared to deficient mice that did not
receive cells (Figure 2C) and Figure S2. NOS2 induction is a major
IFNc-dependent effector mechanism controlling defense against
Mtb in mice, yet our results show that C7 T cells that produce
IFNc are similarly protective in WT and NOS2-deficient hosts.
Taken together, our results demonstrate the existence of an IFNc/
NOS2-independent mechanism of CD4 T cell mediated killing of
Mtb that is operative at the early time points examined in this
study.
Optimal control of M. tuberculosis growth can be
independent of IFNc and TNF production by effector T
cells
Tumor necrosis factor (TNF) is another critical regulator of host
defense that is secreted by Th1 CD4 T cells. The precise
contribution of TNF to defense against Mtb infection is difficult to
define since it has been implicated in lymphocyte recruitment, cell
survival, and mycobacterial killing [3,15,16]. We next determined
whether TNF deficient C7 cells could protect WT and TNF
deficient mice from Mtb infection. The protection provided to
recipient mice either by WT or TNF deficient C7 effector cells was
comparable, demonstrating that TNF production by effector CD4
T cells is not required for protection against Mtb infection
(Figure 3A). Similarly, TNF-deficient naı ¨ve C7 T cells provided
the same level of protection as adoptively transferred wild-type C7
T cells (Figure S1B). Experiments using TNF deficient hosts
showed that TNF deficient effectors reduced the number of
bacteria by ,100 fold, compared to TNF deficient hosts that did
not receive C7 effectors (Figure 3B). Although adoptively
transferred TNF-deficient C7 effectors were slightly less effective
than WT C7 effectors at providing protection in TNF deficient
recipients, TNF-deficient C7 effector T cells still provided a high
degree of protection in TNF deficient recipients, an effect that
Figure 2. IFN-gamma and iNOS independent control of M. tuberculosis infection. ESAT-6 specific Th1-skewed CD4 effector cells were
transferred into mice which were subsequently aerosol infected with ,100 CFU of Mtb. Twenty-one days later lungs were harvested and plated to
determine bacterial numbers. (A/B) M. tuberculosis numbers in the lungs of WT or IFNc-deficient mice that either did not receive effector T cells, or
received WT or IFNc-deficient (ko) T cells. (C) Bacterial numbers harvested from either WT, or iNOS ko, mice that either did not receive effector T cells,
or received Th1-skewed cells generated from WT ESAT-6 specific CD4 T cells. The data presented represents the combination of 2–3 experiments with
3–5 mice per group. Differences were calculated using unpaired Student’s t test.
doi:10.1371/journal.ppat.1002052.g002
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PLoS Pathogens | www.plospathogens.org 3 May 2011 | Volume 7 | Issue 5 | e1002052Figure 3. Optimal control of M. tuberculosis growth requires production of IFNc and TNF by effector T cells. As in Figure 2, ten million
(A–D) or one million (E) Th1-skewed ESAT-6 specific cells were transferred into the indicated hosts that were subsequently infected with Mtb. (A/B)
Bacterial numbers in the lungs of WT or TNF deficient (ko) mice that either did not receive effector T cells, or received WT or TNF deficient effector
cells. Bacterial numbers were determined 21 days post infection. The data are a combination of 2–3 experiments with 3–4 mice per group.
(C) Pictures of lungs from 3 mice from the indicated experimental groups at day 21 post infection. (D) Bacterial numbers at the indicated times
harvested from either WT mice that either did not receive cells, or received Th1-skewed WT or IFNc.TNF dbl deficient cells. Each dot is the average of
7 mice from two independent experiments. Error bars mark SEM. (E) Bacterial numbers from mice receiving either no cells or 1 million C7 effector
cells from the indicated donors. Differences were calculated using unpaired Student’s t test (A, B, D), or calculated by one way ANOVA (E)
***p,0.0001.
doi:10.1371/journal.ppat.1002052.g003
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TNF deficient hosts having large lesions that are diminished in size
in TNF deficient recipients of either WT or TNF deficient C7
effectors (Figure 3C).
It is possible that the protection provided by IFNc or TNF
deficient C7 T cells might result from partial functional
redundancy of these two cytokines. To test this idea, we generated
C7 cells lacking both IFNc and TNF (C7.IFNc.TNF dbl deficient
cells), and transferred these cells, following in vitro Th1
differentiation, into WT hosts and then infected with Mtb.
Bacterial numbers were determined 8, 12, 16, and 22 days
following aerosol infection and compared to control animals
(recipients of WT effectors, or, animals that did not receive cells).
The data in Figure 3Dc demonstrate that when C7 T cells are
unable to produce both TNF and IFN, their capacity to provide
protection is modestly restricted. In comparison to mice that did
not receive T cells and mice that received wild type C7 Th1 cells,
double deficient T cells continued to provide ,60% of maximal
protection. TNF and IFNc double deficient naı ¨ve C7 T cells also
conferred protection against Mtb (Figure S1B). These results
indicate that CD4 T cells, independent of both TNF and IFNc,
provide roughly 10 to 15 fold inhibition of Mtb growth.
We considered the possibility that the gamma/TNF indepen-
dent pathway of antimycobacterial immunity demonstrated above
might depend on cell dose. In the above experiments, the high cell
dose (10 million) might allow a minor pathway of antimycobacter-
ial immunity to substitute for the gamma/TNF pathway. To
address this question, we repeated our experiments with one
million transferred cells, which in our prior experience still
provided substantial killing of M. tuberculosis [13]. One million
transferred WT C7 cells reduced the bacterial load in the lungs of
infected mice by 160 fold compared with animals that received no
cells (Figure 3E). One million IFNc deficient T cells retained
substantial antimycobacterial effect, reducing bacterial loads by 36
fold compared to control animals (Figure 3E). Similarly, TNF
deficient cells reduced bacterial loads by 74 fold. IFNc/TNF
deficient cells were somewhat impaired in their antimycobacterial
effect, but still reduced bacterial loads by 23 fold. Taken together,
these experiments indicate both IFNc/TNF dependent and
independent pathways of T cell mediated protection. The majority
of protection conferred by the C7 cells is, however, IFNc
independent, even at lower T cell doses.
Cytolysis via perforin and FAS are not required to control
of M. tuberculosis infection
MHC-class II restricted cytolytic activity has been observed
following Mtb infection and has been suggested to contribute to
protective immunity [17,18]. Since Mtb-specific cells deficient in
both IFNc and TNF protected mice from infection, we
investigated whether ESAT-6-specific CD4 T cell cytolytic activity
contributed to in vivo protection. To determine whether C7
effector cells killed target cells presenting the ESAT-6 epitope in
vivo, we transferred C7 WT or C7.IFNc.TNF double deficient
CD4 T cells into mice and 3 days later injected these mice with
CFSE-labeled, ESAT-6-coated target cells. We detected approx-
imately 60–80% specific lysis of ESAT-6-coated target cells in
recipients of either C7.WT or C7.IFNc.TNF double deficient
effectors (Figure 4A and B). This high degree of cytolysis is similar
to what was observed for endogenous populations of Mtb-specific
CD4 T cells [17]. To determine the contribution of perforin in
CD4 T cell-mediated protection against Mtb infection, we
compared bacterial numbers in infected mice that did not receive
cells to recipients of C7.WT or C7.perforin deficient, Th1-
differentiated effector T cells. Figure 4C- demonstrates that
perforin deficient T cells were able to restrict Mtb growth to the
same extent as wild type T cells, indicating that perforin-
mediated cytolytic activity does not contribute to the T cell-
mediated control of mycobacterial infection we observe.
Mice lacking functional FAS or FASL are more susceptible to
Mtb infection than WT animals [19]. To determine if FAS
mediated signaling contributes to C7 T cell-mediated protection of
mice from Mtb infection, we modified our adoptive transfer
protocol since C7.WT cells transferred before infection into FAS
deficient hosts were undetectable 21 days following infection (data
not shown). Instead of transferring C7 cells prior to infection, C7
effector cells were transferred 7 days following infection and
bacterial numbers were measured 7 days later. The shorter
experiment led to a similar recovery of C7 cells in WT and FAS
deficient hosts (data not shown). Figure 4D( shows that deficiency
in FAS signaling did not alter the ability of C7 effectors to protect
against Mtb infection, since comparable bacterial numbers were
cultured from WT and FAS deficient recipient mice. Elimination
of both perforin and FAS had only a minor, albeit statistically
significant effect on protection mediated by C7 cells Figure 4E). In
addition, Perforin deficient C7 cells were also as capable as
C7.WT cells at protecting iNOS deficient mice from infection
(Figure S3). Taken together, these results demonstrate that early
control of mycobacterial infection does not require CD4 T cells to
kill Mtb-infected target cells by FAS or perforin-mediated cytolytic
activity.
Optimal protection to M. tuberculosis requires a Th-1
lineage population, yet is independent of T-bet
Because no single Th1-associated effector pathway was essential
for T cell mediated protection against Mtb infection (i.e., IFNc,
TNF, perforin, and FAS), we asked whether protection is a general
property of helper T cells regardless of their effector phenotype.
To address this question, naı ¨ve C7 cells were differentiated into
Th2 and Th17 cells and transferred into WT hosts prior to Mtb
infection. C7 TCR tg mice were crossed to the T-bet deficient
background to prevent in vivo conversion of Th2 and Th17
populations into cells with a Th1 profile (AMG and EGP
unpublished data, and [20]). Twenty-one days following infection,
lungs were harvested from infected animals and the frequencies
and phenotypes of transferred populations were determined
(Figure 5). While frequencies of Th1-skewed cells (on either a
WT or T-bet deficient background), and Th17-skewed cells were
similar, compared to these populations, the frequencies of Th2-
skewed cells were reduced. Of note, adoptively transferred T cells,
including Th2-skewed cells, inhibited the priming of host-derived
endogenous populations of ESAT-6 specific cells, indicating that
adoptively transferred cells were participating in the immune
response (Figure S4). Since the degree of inhibition is directly
correlated with the number of transferred effector cells (data not
shown and [21]), we concluded from this result that recipient mice,
at least at the time of endogenous T cell priming, harbored similar
frequencies of adoptively transferred cells.
The cytokine and transcription factor profiles of adoptively
transferred T cells correspond to the expected phenotypes based
on the in vitro culturing conditions [22]. As expected, while WT
Th1 cell populations contained IFNc producing cells, all T-bet
deficient cells examined (i.e., Th1, Th2, and Th17 skewed cells)
did not produce detectable levels of IFNc (Figure 5B). Th2-
differentiated T-bet deficient C7 T cells expressed IL4 and
GATA3, while Th17-skewed C7 cells expressed IL17 and RORct
(Figure 5B and C). Th1-skewed T-bet deficient C7 T cells also
expressed IL17 and RORct, albeit in lower proportions. Figure 5D
demonstrates that Th2-skewed cells marginally protected mice
Gamma Interferon Independent Mtb Immunity
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feature of all effector CD4 T cells. Th1-skewed, T-bet-deficient C7
T cells protected mice as well as Th1-skewed, WT C7 T cells,
corroborating our finding that IFNc production by Mtb-specific
CD4 T cells is unnecessary for early protection against Mtb
infection. T-bet deficient C7 T cells differentiated under Th17
conditions provided protection, however [23], we consistently
observed better protection by Th1-differentaited, T-bet deficient
C7 T cells, despite seemingly similar cytokine and transcription
factor profiles between these two populations (Figure 5B and C).
Taken together, our results suggest that protection against Mtb
infection is optimal when effector T cells are differentiated under
Th1 conditions, however in a T-bet independent fashion.
IFNc and TNF are central to host defense against Mtb infection
in both mice and humans. However, because these cytokines have
pleiotropic roles in T cell differentiation, cell trafficking, and
macrophage activation, and are produced by a wide variety of
immune cells, the exact mechanism(s) by which they confer
protection has not been clearly defined. One predominant model
is that Th1 effector T cells, which are known to produce both
IFNc and TNF, are the important in vivo sources of these
cytokines and thereby activate macrophage mycobactericidal
effector functions. However, there have been occasional reports
in which protection against Mtb infection did not correlate with
production of IFNc by CD4 effector cells [5,8,9,10], suggesting
either that other cellular sources of these cytokines are important,
or that IFNc independent mechanisms of protection may exist.
The data presented here provide strong support for a mycobacter-
icidal effector function of CD4 T cells that is independent of both
IFNc and TNF. These results may indicate that the central role of
these cytokines is to prime CD4 differentiation to the Th1
phenotype, after which other effector functions kill Mtb. When
cells with a Th1 phenotype are supplied, IFNc becomes
dispensable. Our findings do not dispute the evidence that IFNc
plays an essential role in immunity to Mtb, rather they show that
antigen experienced effector cells have mechanisms to control
infection that do not rely on IFNc mediated signals [24,25]. When
these cells are supplied at the time of infection, T cells can be
highly effective at limiting Mtb growth. Our findings suggest that
vaccination strategies that seek to maximize IFNc producing CD4
T cells may miss an important effector mechanism of Th1 CD4 T
cells that we demonstrate is highly effective at controlling Mtb
growth in vivo. Further exploitation of this new pathway therefore
holds promise for the design of vaccines to control Mtb infection.
Materials and Methods
Mice
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the MSKCC Institutional Animal Care
and Use Committee. No non-human primates were used in this
research. C57BL/6J mice, iNOS ko (#002609), and FAS deficient
mice (#000482) were purchased from Jackson Laboratory.
C7.IFNc ko, C7.TNF ko, C7.IFNc.TNF dl ko, C7.perforin ko,
C7.T-bet ko, IFNc ko, TNF ko, and gp91 phox ko mice were
maintained at the animal facility in the memorial Sloan-Kettering
Figure 4. Cytolysis via perforin and FAS are not required for control of M. tuberculosis infection. (A/B) Th1-skewed ESAT-6 specific cells
were transferred into WT mice (expressing CD45.2) that were subsequently transfused i.v. with equal numbers of CD45.1 CFSE
high, ESAT-6 peptide-
pulsed splenocytes, and CFSE
low control peptide-pulsed (Listeria lysin O, LLO) splenocytes. (A) In vivo cytotoxicity was assessed 16 hours later by flow
cytometry. Dot plots of CFSE and MHC class II levels on CD45.1 splenocytes in recipient mice. The numbers represent frequencies of cells within each
quadrant. (B) Cumulative data from two independent experiments from 3–4 mice per group. (C–E) Th1-skewed ESAT-6 specific cells from the
indicated backgrounds were transferred into either WT or FAS deficient mice. Bacterial numbers were determined 21 days post infection. Experiments
were performed 2 times with 3–5 mice per group. Statistical significance was calculated using the unpaired Student’s t test.
doi:10.1371/journal.ppat.1002052.g004
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were confirmed by PCR analysis and phenotypic confirmation of
the transgenic T cells was performed by intracellular staining
(C7.IFNc ko, C7.TNF ko, C7.IFNc.TNF dbl ko, C7.T-bet ko).
The Memorial Sloan-Kettering Institutional Animal Care and Use
committee approved all animal procedures.
Generation of effector T cells
4610
6 purified C7 TCR tg CD4+T cells were cultured with
12610
6 irradiated T cell–depleted splenocytes and 5 mg/ml of
ESAT-6 1–20 peptide. At days 2 and 3 of culture, the cells were
split 1:2, and 50 U/ml IL-2 was added (R&D Systems). For Th1
cultures, 10 ng/ml IL-12, and 5 mg/ml of neutralizing anti–IL-4
antibody (R&D Systems) were added at day 0 of culture. For Th17
cultures, 10 mg/ml of anti-IFNc and anti-IL-4 and 5 ng/ml of
hTGF-b, 20 ng/ml of IL6 and 20 ng/ml of IL-23 were added at
day 0 of culture. For Th2 cultures, 10 mg/ml of anti-IFNc. and
20 ng/ml of IL4 were added to cultures.
Aerosol infections with M. tuberculosis and generation of
M. tuberculosis Erdman strains
Mice were infected at 8–10-wks of age with M. tuberculosis
Erdman and plated as described [13] M. tuberculosis Erdman strain,
Desat6::hyg (SSM6), has a deletion in the gene encoding ESAT-6
[26]. This strain was complemented with PMH406, which
integrates at the chromosomal attB site, which uses the mop
promoter to drive expression of CFP-10 and ESAT-6 [27]. Either
wild type ESAT-6 or mutated ESAT-6 in which amino acid
number 12 was changed from glutamic acid to alanine (E12A)
were used to generate Desat6::hyg attB::pMH406 or Desat6::hyg
attB::pMH406-ESAT6(E12A) .
Statistical analysis
For comparison of means between two groups we performed the
unpaired Student’s t test in GraphPad Prism software. For
experiments that involved more than three groups (e.g
Figures 3E, 5A, 5D), we compared the groups using a one way
ANOVA with a Bonferroni’s multiple comparison test.
Supporting Information
Figure S1 IFNc independent control of Mtb infection by
endogenous T cell populations or naı ¨ve C7 cells. (A) To generate
bone marrow-chimeras, RAG ko mice were transplanted with BM
from the indicated donors, for mixed BM- chimeras, 50% of the
BM came from either WT or IFNc ko mice. Animals were infected
,8 weeks post transplant with Mtb. The data shows lung bacterial
numbers 21 days post infection. (B) Naı ¨ve C7 cells have an IFN
gamma independent pathway of antimycobacterial immunity.
Figure 5. Optimal protection to M. tuberculosis requires a Th-1 lineage population, yet is independent of T-bet. ESAT-6 specific CD4 T
cells from the indicated genetic backgrounds were activated for 4 days under Th1, Th2 or Th17 skewing conditions before transfer into the WT mice.
Two days after transfer, mice were aerosol infected with ,100 CFU of Mtb. Twenty-one days later lungs were harvested to determine frequencies and
phenotypes of the transferred T cells and lungs were plated to determine bacterial numbers. (A) Frequencies of the transferred populations in the
lungs of infected mice, as determined by flow cytometry. (B) Frequencies of IL2, IFNc, TNF, IL17A, and IL4 producing cells among the transferred
effector populations harvested from the lungs. (C) Histogram plots following intracellular staining for the indicated transcription factors. The gate
marks the frequencies of RORct bright cells. (D) Bacterial numbers in the lungs 21 days post infection. *** p,0.0001 calculated by one way ANOVA.
doi:10.1371/journal.ppat.1002052.g005
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PLoS Pathogens | www.plospathogens.org 7 May 2011 | Volume 7 | Issue 5 | e100205210,000 naı ¨ve C7 cells of the indicated genotype were transferred
on the day before infection and bacterial loads in the lungs of
infected mice were determined 22 days after infection. * p,0.05;
** p,0.001 calculated by one way ANOVA.
(PDF)
Figure S2 C7 effector cells protect PHOX ko mice from Mtb
infection. Bacterial numbers of either WT or PHOX ko mice that
either did not receive cells or received WT Th1-skewed C7
effector cells. The data shows lung bacterial numbers 21 days post
infection. Differences were compared using unpaired Student’s t
test.
(PDF)
Figure S3 C7.perforin ko effector cells protect iNOS ko mice
from Mtb infection. Bacterial numbers 21 days post infection in
iNOS ko mice that either did not receive effector cells or received
either perforin ko or WT Th1 skewed effector cells. Differences
were tested using unpaired Student’s t test.
(PDF)
Figure S4 C7 effector T cells prevent activation of host-derived
ESAT-6 specific cells. C7 CD4 T cells from the indicated genetic
backgrounds were activated in vitro under Th1, Th2, or Th17-
skewing conditions. These cells were transferred into B6 mice that
were subsequently infected with Mtb. Twenty-one days later, the
frequencies of host-derived ESAT-6 specific cells in the lungs were
determined by intracellular cytokine staining following ESAT-6
stimulation. (A) Flow cytometry plots gated on host-derived CD4
T cells, demonstrates that host-derived ESAT-6 specific cells (IFNg
+ TNF +) are undetectable in animals that received Th1, Th2, and
Th17-skewed cells. (B) Analysis from 5–10 mice per experimental
group.
(PDF)
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